Toxic epidermal necrolysis (TEN) in elderly patients.

Toxic epidermal necrolysis (TEN) is a severe exfoliative disease of the skin and mucous membranes that results in high mortality. As the elderly population increases, the number of elderly patients with TEN can also be expected to increase. Elderly patients with comparably sized burn wounds usually have a poor prognosis. Our purpose was to determine whether elderly TEN patients exhibit similarly high mortality. A retrospective review was conducted of 52 patients treated for TEN from October 1991 through September 1998. Eleven patients were older than 65 years. All patients were treated according to our TEN protocol. Eight of 11 patients recovered, and 3 died. The mean total body surface area (TBSA) involvement for the patients who recovered was 24%, compared with 66% for the nonsurvivors. The survival rate for elderly patients (73%) compares well with that for those younger than 65 years (89%). Therefore, we propose that we should be aggressive in treating elderly patients with TEN.

[1]  C. Ryan,et al.  A 10-year experience with toxic epidermal necrolysis. , 2000, The Journal of burn care & rehabilitation.

[2]  C. González‐Herrada,et al.  Treatment of toxic epidermal necrolysis with cyclosporin A. , 2000, The Journal of trauma.

[3]  K. Dunn,et al.  Experience with severe extensive blistering skin disease in a paediatric burns unit. , 2000, Burns : journal of the International Society for Burn Injuries.

[4]  P. Kennedy,et al.  Clinical manifestations and outcomes in 17 cases of Stevens–Johnson syndrome and toxic epidermal necrolysis , 1999, The Australasian journal of dermatology.

[5]  E. C. Smoot,et al.  Treatment issues in the care of patients with toxic epidermal necrolysis. , 1999, Burns : journal of the International Society for Burn Injuries.

[6]  J. Tschopp,et al.  Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. , 1998, Science.

[7]  A. Munster,et al.  Toxic Epidermal Necrolysis Syndrome: Mortality Rate Reduced with Early Referral to Regional Burn Center , 1998, Plastic and reconstructive surgery.

[8]  M. Schurr,et al.  Toxic epidermal necrolysis: an analysis of referral patterns and steroid usage. , 1997, The Journal of burn care & rehabilitation.

[9]  D. Loannides,et al.  Plasmapheresis in toxic epidermal necrolysis , 1997, International journal of dermatology.

[10]  J. Kucan,et al.  Toxic Epidermal Necrolysis: A Review and Report of the Successful Use of Biobrane for Early Wound Coverage , 1995, Annals of plastic surgery.

[11]  J. Kucan.  Use of Biobrane in the treatment of toxic epidermal necrolysis. , 1995, The Journal of burn care & rehabilitation.

[12]  A. Mason,et al.  Burn center care for patients with toxic epidermal necrolysis. , 1995, Journal of the American College of Surgeons.

[13]  D. Herndon.  Toxic epidermal necrolysis: a systemic and dermatologic disorder best treated with standard treatment protocols in burn intensive care units without the prolonged use of corticosteroids. , 1995, Journal of the American College of Surgeons.

[14]  J. Roujeau,et al.  Toxic epidermal necrolysis (Lyell syndrome). , 1990, Journal of the American Academy of Dermatology.

[15]  J. Grant-Kels,et al.  Drug‐Induced Toxic Epidermal Necrolysis Treated with Cyclosporin , 1989, International journal of dermatology.

[16]  D. Heimbach,et al.  Toxic Epidermal Necrolysis: A Step Forward in Treatment , 1987 .

[17]  B. Czarnetzki,et al.  Plasmapheresis in severe drug-induced toxic epidermal necrolysis. , 1985, Archives of dermatology.

[18]  D. Heimbach,et al.  Improved treatment of the Stevens-Johnson syndrome. , 1984, Archives of surgery.

[19]  R. G. Cornell,et al.  Improvements in burn care, 1965 to 1979. , 1980, JAMA.

[20]  D. Becker.  Toxic epidermal necrolysis , 1969, The Lancet.